Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study
Introduction
Cancer is a significant health problem in older persons [1], [2]. Nevertheless, the manifestations and course of cancer in the older population have not been well investigated and remain poorly understood [3], [4], [5], [6], [7], [8]. The USA National Cancer Center Network (NCCN) and the International Society of Geriatric Oncology (SIOG) have both recommended some form of geriatric assessment despite that the optimal form has yet to be established but they expect benefits in terms of independence and quality of life [9], [10]. However, a geriatric assessment is time consuming and the benefits have not yet been demonstrated in this patient population. A more sensitive way to characterize health and functional status it to use the concept of frailty. It represents a state of reduced homeostasis and resistance to stress that leads, in turn, to increased vulnerability and risk of adverse outcomes. Fried et al. [11] have developed a now commonly used approach to measure frailty which includes weakness, poor endurance, reduced physical activity, slow walking speed, and unintentional weight loss during the preceding year. More recently, it has been suggested to include mood disturbance and cognitive impairment suspicion as characteristics of frailty [12], [13], [14], [15].
Unlike their non-frail contemporaries, frail older individuals appear unable to withstand stressors, such as environmental stress, injury, and acute illness. These stressors may provoke a downward spiral, whereby the frail older individual is unable to recover and return to the baseline state [11], [16], [17]. In older patients, cancer treatments are considered strong stressors that will reveal which patients have sufficient functional reserve to regain stable homeostasis [5], [17].
Some of the adverse outcomes of cancer and its treatment are hospitalization or emergency department or general practitioner visits. However, no study has investigated if frailty predicts the use of health care services in older newly-diagnosed cancer patients.
Furthermore, research on the use of health care services by older cancer patients is sparse and most of the research conducted is focused on end of life care. Nevertheless, the prospective studies by Kurtz et al. [18], [19] examined the use of care in the US after the cancer diagnosis, following 909 participants for 1 year. These authors reported that those with poor physical functioning and more co morbidities had increased service utilization. As the patients were included 4–6 weeks after surgery or within 2–4 weeks of the start of radiation or chemotherapy treatments, the baseline physical functioning was perhaps already compromised by the treatments received. Stafford et al. reported higher services use (defined as Medicare reimbursements) in older cancer patients compared to older patients with other co morbidities in the US [20], but the timing of the cancer diagnosis in relation to the service use was not reported. Lastly, the study of Johansson et al. [21] in Sweden investigated the determinants of cancer patient's hospital utilization in the first 2 years after diagnosis. They reported that in addition to treatment and stage of cancer, co-morbidity, low physical functioning, pain and some economic variables predicted the number of days spent in hospital but again some of these participants had received treatment prior to the baseline interview.
On this background of little research, it remains important to examine the predictive ability of the concept of frailty particularly if this concept is to be useful in clinical practice. Early identification of patients that are high users of care might contribute to the development of interventions to improve patient management and reduce inpatient service use. As there was no prospective observational study on health, frailty and adverse outcomes of cancer and its treatment, the aims of our pilot study were (1) to assess the feasibility of recruitment, retention and the methods used in this study and (2) to describe the health and vulnerability of older cancer patients and to explore the association between frailty and use of health care (hospitalization, emergency department (ED) and general practitioner (GP) visits). This paper presents the results of the second aim. The results of the first aim will be presented in a separate paper.
Section snippets
Study design and patients
This pilot study was a prospective observational cohort study [22]. The inclusion criteria were: patients referred to the Segal Cancer Centre of the Jewish General Hospital, McGill University, Montreal, Canada, aged 65 and older, with a new diagnosis of breast, colorectal or a lung tumour with or without metastasis or haematological malignancy (i.e. lymphoma and myeloma), who had not received cancer treatment in the previous 5 years. The only exception was for those who had started hormonal
Results
Recruitment began on March 1st 2007 and ended on January 31st 2008 for all cancers except colorectal cancer for which recruitment ended on May 1st 2008. During this period, a total of 112 patients (out of 156 contacted) agreed to participate (response 72%). The only difference in baseline characteristics between participants and those who refused was that those who participated were less often married or living common-law (55.4% of participants vs. 77.5% of refusers, p = 0.006). Some patients
Discussion
The aim of analyses presented in this paper was to investigate whether frailty predicted the use of health care in older newly-diagnosed cancer patients. The results of this prospective pilot study showed that although many patients had one or more frailty markers present at baseline, there was little evidence of an association between the frailty markers and health care use in this prospective pilot study. Only cognitive impairment suspicion predicted ED visits which has been reported
Conflict of interest statement
There was no conflict of interest.
Reviewers
Catherine Terret, MD, PhD, Centre Léon Bérard, Department of Medical Oncology, 28, rue Laënnec, F-69373 Lyon cedex 08, France.
MJ Molina-Garrido, PhD, General Hospital Virgen de la Luz in Cuenca, Hermandad Donantes de Sangre, s/n, Cuenca, Spain.
Acknowledgements
We thank all of the participants who gave of their time during a very difficult period of their life to participate in our study. In addition, we very much appreciate the support of staff and volunteers of the Segal Cancer Centre. We thank Ms. Lily Shatsky for her valuable comments and suggestions to the study design and conduct of the study.
This study was supported through a post PhD research fellowship from the Canadian Cancer Society/National Cancer Institute of Canada to Dr. M. Puts. The
Martine Puts is an assistant professor at the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto. She was a Post Doctoral Fellow at the Department of Epidemiology, Biostatistics and Occupational Health and Solidage McGill University/Université de Montreal Research Group on Frailty and Aging. She received her Ph.D. at the Longitudinal Aging Study Amsterdam (LASA), at the VU University Medical Centre, Amsterdam, the Netherlands.
References (47)
- et al.
Cancer in the elderly: Why so badly treated?
Lancet
(1990) - et al.
Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE working group
Crit Rev Oncol Hematol
(2000) - et al.
Treatment of cancer in old age, shortcomings and challenges
Neth J Med
(2001) - et al.
Cancer rates, medical comorbidities, and treatment modalities in the oldest patients
Crit Rev Oncol Hematol
(2008) - et al.
Cancer in the older person
Cancer Treat Rev
(2005) - et al.
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the international society of geriatric oncology (SIOG)
Crit Rev Oncol Hematol
(2005) - et al.
The frailty syndrome: a critical issue in geriatric oncology
Crit Rev Oncol Hematol
(2003) Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?
Med Hypotheses
(2006)- et al.
The development of a comorbidity index with physical function as the outcome
J Clin Epidemiol
(2005) - et al.
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
J Psychiatr Res
(1975)
International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results
J Psychosom Res
Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions
Ann Emerg Med
Future of cancer incidence in the United States: burdens upon an aging, changing nation
J Clin Oncol
Cancer in the frail patient. A coming epidemic
Hematol Oncol Clin North Am
Frailty in older adults: evidence for a phenotype
J Gerontol A Biol Sci Med Sci
Sex differences in the risk of frailty for mortality independent of disability and chronic diseases
J Am Geriatr Soc
From bedside to bench: research agenda for frailty
Sci Aging Knowledge Environ
Editorial: something about frailty
J Gerontol A Biol Sci Med Sci
Frailty: an emerging research and clinical paradigm issues and controversies
J Gerontol A Biol Sci Med Sci
Utilization of services among elderly cancer patients—relationship to age, symptoms, physical functioning, comorbidity, and survival status
Ethnicity Dis
Predictors of use of health care services among elderly lung cancer patients: The first year after diagnosis
Support Care Cancer
Cited by (36)
In-Hospital Outcomes of Patients on Maintenance Dialysis With Frailty: 10-year Results From the US National Inpatient Sample Database
2020, Journal of Renal NutritionCitation Excerpt :In community-dwelling older adults (≥65 years), the prevalence of frailty is 7%. Frail older adults, regardless of their comorbidity and disability status, are at twice the risk of mortality and hospitalization3,4 as well as other adverse outcomes, including falls, decreased mobility, physical limitations,5,6 respiratory impairment,7 and cognitive decline.8 Frailty is extremely common among patients of all ages with end-stage renal disease (ESRD).9
Hope to hope: Experiences of older people with cancer in diverse settings
2019, European Journal of Oncology NursingCitation Excerpt :However there are challenges in providing hope for older people with cancer (Lannie, 2014). The older person commonly presents with a complexity of symptoms and can have multi morbidity which further makes the diagnosis and assessment of needs a challenge (Puts, 2010). Older people are also subject to being cared for in diverse settings so the chance to build up a therapeutic relationship is also lessened as people are seldom in the same ward for acute episodes.
Non-programmed hospitalization of elderly patients with cancer: Which care pathway?
2019, Bulletin du CancerHealth status, emergency department visits, and oncologists’ feedback: An analysis of secondary endpoints from a randomized phase II geriatric assessment trial
2019, Journal of Geriatric OncologyCitation Excerpt :However, this may in part explain the small differences between the two groups in terms of healthcare utilization and other outcomes. The use of healthcare by newly diagnosed older patients with cancer is substantial, and most hospitalizations are cancer-related [13]. Research shows that ED visits may indicate unmet healthcare needs related to issues with continuity of care and accessibility to primary care services [15,16].
Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study
2018, Journal of Geriatric OncologyCitation Excerpt :Most of these patients will appropriately be considered for surgery [5,6], despite having a higher number of comorbidities that may increase postoperative complication risk [7–12]. Adverse events after BC surgery have been extensively studied, however the use of emergency services by older patients after BC surgery has not yet been adequately characterized [13,14]. Care within EDs is challenged by overcrowding, time-constraints, incomplete clinical information, and limited multidisciplinary, senior-specific resources [15–21].
A Research Agenda for Gero-Oncology Nursing
2016, Seminars in Oncology Nursing
Martine Puts is an assistant professor at the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto. She was a Post Doctoral Fellow at the Department of Epidemiology, Biostatistics and Occupational Health and Solidage McGill University/Université de Montreal Research Group on Frailty and Aging. She received her Ph.D. at the Longitudinal Aging Study Amsterdam (LASA), at the VU University Medical Centre, Amsterdam, the Netherlands.
Johanne Monette is a geriatrician, with an M.Sc. in Epidemiology and Biostatistics. She is an assistant professor in the Department of Medicine at McGill University. She is the scientific director of the Collaborative Research Network in Long-Term Care (http://www.solidage.ca/e/CRNLTC.htm). Dr. Monette is an active member of the McGill Geriatric Oncology Interest Group.
Veronique Girre is medical oncologist at the Institut Curie in Paris, France. She is in charge of the geriatric oncology program at the Institut Curie. She trained as a fellow at the Division of Geriatric Medicine, McGill University, Montreal, Canada.
Christina Wolfson is a professor of Epidemiology and Biostatistics and of Medicine at McGill University and Director of the Division of Clinical Epidemiology at the McGill University Health Centre. Her program of research lies in the epidemiology of neurodegenerative disorders, including dementia, multiple sclerosis, amyotrophic lateral sclerosis and Parkinson's disease. She is currently co-Principal Investigator on the Canadian Longitudinal Study on Aging, a nationwide 20-year study of 50,000 participants aged 45–85. Dr. Wolfson received her Ph.D. in Epidemiology and Biostatistics from the Department of Epidemiology & Biostatistics at McGill University.
Michele Monette, occupational therapist, received her M.Sc. in Biomedical Sciences at Université de Montreal. She is a research associate at the Solidage McGill University/Université de Montreal Research Group on Frailty and Aging.
Gerald Batist is Minda de Gunzburg Professor & Chair of the Department of Oncology, McGill University, and Director of the Segal Cancer Centre at the Jewish General hospital. In 1995, he founded the McGill Centre for Translational Research in Cancer, with the aim of stimulating rapid translation of new discoveries in the research laboratory into clinical benefits for patients. He is a medical oncologist and runs a research program in molecular pharmacology, working on novel cancer therapeutics.
Howard Bergman is the Dr. Joseph Kaufmann Professor of Geriatric medicine and professor in the Departments of Medicine, Family Medicine and Oncology. His research interests include frailty, chronic disease, Alzheimer disease, integrated care and population health.